RxDoctor Payments Data

Jay Hertel, DO

Family Medicine · Redondo Beach, CANPI 1629091897

Payments from drug & device makers

$859in general payments, 2019–2025

Across 44 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$210
  • AstraZeneca$103
  • Lilly USA, LLC$64
  • Novo Nordisk$60
  • Abbott$59
  • Eisai Inc.$52
  • plus $312 from 12 others

What the payments were for

  • Food & beverage$859100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$859 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$44,260
Medicare patients
148
Services billed
515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$68,564
FarxigaDapagliflozin Propanediol31$43,646
OzempicSemaglutide20$37,910
JardianceEmpagliflozin32$31,794
TrulicityDulaglutide18$27,816
JanuviaSitagliptin Phosphate15$21,158
Synjardy XrEmpagliflozin/Metformin Hcl13$16,380
Atorvastatin Calcium591$5,998
Levothyroxine Sodium254$4,546
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$3,933
Wixela InhubFluticasone Propion/Salmeterol22$3,906
Fenofibrate123$3,164
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen115$2,968
Rosuvastatin Calcium166$2,477
Metformin Hcl277$2,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$43$68,56460 claims
AstraZenecaFarxiga$103$43,64631 claims
Novo NordiskOzempic$60$37,91020 claims
Lilly USA, LLCTrulicity$64$27,81618 claims
MerckJanuvia$19$21,15815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Redondo Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →